U.S. burden of Alzheimer's disease, related dementias to double by 2060
The U.S. burden of Alzheimer’s disease and related dementias (ADRD) will double by 2060, according to a new study from the Centers for Disease Control and Prevention.
WordPress database error: [Table 'acdlpb3_wp339.wpe5_wpsecure_login' doesn't exist]SHOW COLUMNS FROM wpe5_wpsecure_login LIKE "country"
WordPress database error: [Table 'acdlpb3_wp339.wpe5_wpsecure_login' doesn't exist]ALTER TABLE wpe5_wpsecure_login ADD country VARCHAR(150)
WordPress database error: [Table 'acdlpb3_wp339.wpe5_wpsecure_login' doesn't exist]ALTER TABLE wpe5_wpsecure_login ADD city VARCHAR(100)
The U.S. burden of Alzheimer’s disease and related dementias (ADRD) will double by 2060, according to a new study from the Centers for Disease Control and Prevention.
Part 2 of the latest Annual Report to the Nation on the Status of Cancer finds that cancer patients in the United States shoulder a large amount of cancer care costs. In
U.S. cancer survivors face significant economic burdens due to growing medical costs, missed work, and reduced productivity, according to a CDC study.